| Seland Chiropractic Center, P.c. | |
|
7350 Village Square Ln, Fishers, IN 46038-4555 | |
| (317) 598-1410 | |
| (317) 598-9807 |
| Full Name | Seland Chiropractic Center, P.c. |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 7350 Village Square Ln, Fishers, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033304191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (Indiana) | Primary |
| Provider Name | Trond G Seland |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1427021443 PECOS PAC ID: 0042494874 Enrollment ID: I20110401000881 |
News Archive
In an effort to curb the cancer rates, the country has adopted evidence-based treatment guidelines and continues to strengthen a number of strategic collaborations with the National Comprehensive Cancer Network® (NCCN®) as demonstrated by several NCCN programs scheduled throughout China this spring.
Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.
In response to the alarming increase in the overweight and obese population in Kansas, a representative of the American Society of Bariatric Physicians (ASBP) recently testified to the Kansas State Board of Healing Arts. ASBP is America's oldest and most experienced society devoted to the medical treatment of overweight and obesity and associated health conditions and risks.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Seland Chiropractic Center, P.c. 7350 Village Square Lane, Fishers, IN 46038-4555 Ph: (317) 598-1410 | Seland Chiropractic Center, P.c. 7350 Village Square Ln, Fishers, IN 46038-4555 Ph: (317) 598-1410 |
News Archive
In an effort to curb the cancer rates, the country has adopted evidence-based treatment guidelines and continues to strengthen a number of strategic collaborations with the National Comprehensive Cancer Network® (NCCN®) as demonstrated by several NCCN programs scheduled throughout China this spring.
Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.
In response to the alarming increase in the overweight and obese population in Kansas, a representative of the American Society of Bariatric Physicians (ASBP) recently testified to the Kansas State Board of Healing Arts. ASBP is America's oldest and most experienced society devoted to the medical treatment of overweight and obesity and associated health conditions and risks.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
› Verified 4 days ago
Dr. Andrew W Alcorn, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 8924 E 96th St, Fishers, IN 46037 Phone: 317-841-2700 | |
Erich S Zielinski, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 8924 E 96th St, Fishers, IN 46037 Phone: 317-863-8424 Fax: 317-863-8477 | |
Hoosier Chiropractor Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 12816 Ford Dr, Fishers, IN 46038 Phone: 317-585-9111 Fax: 317-585-9115 | |
Olio Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 11394 Olio Rd, Fishers, IN 46037 Phone: 317-849-2200 Fax: 317-849-2212 | |
Dr. Paula Marie Jones, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 14074 Trade Center Dr, Suite 136, Fishers, IN 46038 Phone: 317-410-4242 | |
Mr. Richard G Mason, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 11580 Overlook Dr, 200, Fishers, IN 46037 Phone: 317-577-9558 Fax: 317-577-9559 |